1. Home
  2. SNSE vs INHD Comparison

SNSE vs INHD Comparison

Compare SNSE & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • INHD
  • Stock Information
  • Founded
  • SNSE 2005
  • INHD 2019
  • Country
  • SNSE United States
  • INHD United States
  • Employees
  • SNSE N/A
  • INHD N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • INHD
  • Sector
  • SNSE Health Care
  • INHD
  • Exchange
  • SNSE Nasdaq
  • INHD Nasdaq
  • Market Cap
  • SNSE 12.3M
  • INHD 12.8M
  • IPO Year
  • SNSE 2021
  • INHD 2023
  • Fundamental
  • Price
  • SNSE $0.45
  • INHD $4.50
  • Analyst Decision
  • SNSE Strong Buy
  • INHD
  • Analyst Count
  • SNSE 3
  • INHD 0
  • Target Price
  • SNSE $4.33
  • INHD N/A
  • AVG Volume (30 Days)
  • SNSE 330.7K
  • INHD 33.6K
  • Earning Date
  • SNSE 11-14-2024
  • INHD 02-14-2025
  • Dividend Yield
  • SNSE N/A
  • INHD N/A
  • EPS Growth
  • SNSE N/A
  • INHD N/A
  • EPS
  • SNSE N/A
  • INHD N/A
  • Revenue
  • SNSE N/A
  • INHD $885,495.00
  • Revenue This Year
  • SNSE N/A
  • INHD N/A
  • Revenue Next Year
  • SNSE N/A
  • INHD N/A
  • P/E Ratio
  • SNSE N/A
  • INHD N/A
  • Revenue Growth
  • SNSE N/A
  • INHD 10.72
  • 52 Week Low
  • SNSE $0.38
  • INHD $3.00
  • 52 Week High
  • SNSE $1.94
  • INHD $17.29
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 47.08
  • INHD 43.65
  • Support Level
  • SNSE $0.41
  • INHD $4.40
  • Resistance Level
  • SNSE $0.50
  • INHD $5.12
  • Average True Range (ATR)
  • SNSE 0.05
  • INHD 0.49
  • MACD
  • SNSE -0.00
  • INHD -0.04
  • Stochastic Oscillator
  • SNSE 34.09
  • INHD 6.71

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing highly selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101, SNS-102, SNS-103, SNS-20.

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

Share on Social Networks: